Across Asia Pacific, healthcare and life sciences breakthroughs offer exciting opportunities to meet patient needs and create value, but rising costs and market uncertainty also apply significant pressure to operations and balance sheets.
These dual conditions represent a chance for innovators, investors and healthcare & life sciences businesses to protect, unlock and accelerate growth through both top line and bottom line considerations.
From governments to private investors, big pharma to biotechs, organizations inside and outside the region are reimagining healthcare and…
